DE69131522T2 - Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel - Google Patents

Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel

Info

Publication number
DE69131522T2
DE69131522T2 DE69131522T DE69131522T DE69131522T2 DE 69131522 T2 DE69131522 T2 DE 69131522T2 DE 69131522 T DE69131522 T DE 69131522T DE 69131522 T DE69131522 T DE 69131522T DE 69131522 T2 DE69131522 T2 DE 69131522T2
Authority
DE
Germany
Prior art keywords
antidiabetic
antiviral
innovative
inhibitors useful
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69131522T
Other languages
English (en)
Other versions
DE69131522D1 (de
Inventor
Robert Farr
Norton Peet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69131522D1 publication Critical patent/DE69131522D1/de
Application granted granted Critical
Publication of DE69131522T2 publication Critical patent/DE69131522T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/567—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with sulfur as the only hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
DE69131522T 1991-01-10 1991-12-13 Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel Expired - Fee Related DE69131522T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63963591A 1991-01-10 1991-01-10
US78420891A 1991-10-28 1991-10-28
PCT/US1991/009387 WO1992011867A1 (en) 1991-01-10 1991-12-13 Novel glucohydrolase inhibitors useful as antidiabetic agents

Publications (2)

Publication Number Publication Date
DE69131522D1 DE69131522D1 (de) 1999-09-16
DE69131522T2 true DE69131522T2 (de) 1999-11-25

Family

ID=27093368

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131522T Expired - Fee Related DE69131522T2 (de) 1991-01-10 1991-12-13 Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel

Country Status (15)

Country Link
US (1) US5438069A (de)
EP (1) EP0566666B1 (de)
JP (1) JP2951723B2 (de)
KR (1) KR100192862B1 (de)
AT (1) ATE183100T1 (de)
AU (1) AU660641B2 (de)
CA (1) CA2098927A1 (de)
DE (1) DE69131522T2 (de)
DK (1) DK0566666T3 (de)
ES (1) ES2136615T3 (de)
GR (1) GR3031423T3 (de)
IE (1) IE920087A1 (de)
NZ (1) NZ241234A (de)
PT (1) PT100001B (de)
WO (1) WO1992011867A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650377T2 (de) * 1985-12-23 1996-02-22 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
US6048870A (en) * 1996-10-01 2000-04-11 Glycodesign 3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
EP1023290A1 (de) * 1997-10-24 2000-08-02 Glycodesign Inc. Synthese von swainsoninsalzen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205068A (en) * 1978-05-18 1980-05-27 E. R. Squibb & Sons, Inc. β-Lactamase inhibitor EM4615
EP0056194B1 (de) * 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituierte Pseudo-Aminozucker, ihre Herstellung und Verwendung
US4399224A (en) * 1981-07-13 1983-08-16 A. E. Staley Manufacturing Company Enzymatically treated phosphatides
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4622295A (en) * 1982-09-16 1986-11-11 Wako Pure Chemical Industries, Ltd. Modified oligosaccharides used as substrate for measuring α-amylase activity
ES2058070T3 (es) * 1986-05-09 1994-11-01 Pulverer Gerhard Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.
US4963479A (en) * 1986-10-07 1990-10-16 Hoechst Celanese Corporation Reagent system for an alpha-amylase assay containing aromatic substituted glycoside
US4962097A (en) * 1988-10-28 1990-10-09 Merck & Co., Inc. Method of treating bacterial infection with phosphorus containing DHP enzyme inhibitors
US5032505A (en) * 1988-11-21 1991-07-16 Chembiomed, Ltd. Inhibitors for glycosaminosyl transferase V
US5053399A (en) * 1989-02-03 1991-10-01 University Of Pittsburgh Myo-inositol analogs and methods for their use
US4988682A (en) * 1989-02-03 1991-01-29 University Of Pittsburgh Myo-inositol analogs and method for their use
US5240707A (en) * 1990-04-12 1993-08-31 Merrell Dow Pharma Alpha-mannosidase and fucosidase inhibitors

Also Published As

Publication number Publication date
US5438069A (en) 1995-08-01
KR930703013A (ko) 1993-11-29
AU9176091A (en) 1992-08-17
DK0566666T3 (da) 1999-12-06
GR3031423T3 (en) 2000-01-31
EP0566666A4 (en) 1994-06-08
JPH06504550A (ja) 1994-05-26
WO1992011867A1 (en) 1992-07-23
DE69131522D1 (de) 1999-09-16
ATE183100T1 (de) 1999-08-15
AU660641B2 (en) 1995-07-06
IE920087A1 (en) 1992-07-15
PT100001B (pt) 1999-06-30
EP0566666A1 (de) 1993-10-27
EP0566666B1 (de) 1999-08-11
CA2098927A1 (en) 1992-07-11
KR100192862B1 (ko) 1999-06-15
NZ241234A (en) 1994-07-26
PT100001A (pt) 1993-02-26
ES2136615T3 (es) 1999-12-01
JP2951723B2 (ja) 1999-09-20

Similar Documents

Publication Publication Date Title
SE9604793D0 (sv) New polymorphs
ATE222100T1 (de) Amidino-derivate nützlich als no synthase-hemmer
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
TR199801253T2 (xx) Vitronektin resept�r� antagonistleri.
ATE233561T1 (de) Imidazolverbindungen
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
ATE228507T1 (de) Substituierte 6-phenylphenanthridine
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
DK0755370T3 (da) Insekticide gødningsblandinger
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
ATE197229T1 (de) Zahnbürste
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DE69131522T2 (de) Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel
NO970341D0 (no) Imidazopyridin-azolidinoner
NO941084D0 (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
ES2091039T3 (es) Nuevos bis-fenil-hexenos.
ES2185154T3 (es) Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia.
NO950723L (no) Optisk aktivt hydrokinin-1-(3-aminofenyl)etansulfonat, dets fremstilling og anvendelse
ECSP972052A (es) Quinoxalinadionas
ITMO910013U1 (it) Emanatore di profumo di essenze, ricaricabile, per deodorare e profuma re ambienti.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee